Physician profile
Thomas P Whelan
NPI 1720043227
$842.79
in general payments reported to CMS, 2019-2025
17 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.26 · 2020: $12.75 · 2021: $102 · 2022: $234 · 2023: $92.66 · 2024: $51.43 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $274.56 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $100.20 | 2021-2025 | Unithroid |
| Novo Nordisk INC | $68.93 | 2023-2025 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.12 | 2022-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $54.53 | 2022-2025 | Entyvio |
| Genzyme Corporation | $44.26 | 2025 | |
| Insulet Corporation | $28.99 | 2025 | Omnipod |
| Axsome Therapeutics, INC. | $28.02 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.59 | 2024 | Ofev |
| Sanofi Pasteur INC. | $27.12 | 2023 | |
| Corcept Therapeutics | $22.68 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $22.46 | 2021 | |
| Amarin Pharma, INC. | $20.43 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.26 | 2019 | |
| Seqirus USA INC | $16.75 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2022 | |
| Olympus America INC. | $12.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Whelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.